COVID-19 patients respond positively to Gilead Sciences experimental drug

Shares of Gilead Sciences Inc’s shares jumped by 16% following news reports that its experimental drug remdesivir is proving to be effective in U.S. trials of patients who have been severely afflicted by the COVID-19 disease caused by the coronavirus. According to a report from medical news website STAT, a University of Chicago hospital participating…

U.S. Department of Health and Human Services partners with Regeneron Pharmaceuticals Inc to develop coronavirus therapy

The U.S. Department of Health and Human Services has partnered with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus whose outbreak in China has killed hundreds of people in China alone. The drugmaker collaboration with the U.S. Department of Health and Human Services is the latest to join the race to develop a…